+ All Categories
Home > Documents > Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing...

Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing...

Date post: 14-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
20
Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director @NIDAnews
Transcript
Page 1: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Neurobiological Advances in Addiction Science:

Implications For Prevention and Treatment

Nora D. Volkow, M.D.

Director

@NIDAnews

Page 2: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

0

100

200

300

400

500

600

700

800

900

1000

1100

0 1 2 3 4 5 hr Time After Amphetamine

% o

f B

asa

l R

ele

ase

AMPHETAMINE

0

50

100

150

200

0 60 120 180 Time (min)

% o

f B

asa

l R

ele

ase

Empty

Box Feeding

Di Chiara et al.

FOOD

VTA/SN

nucleus accumbens

frontal cortex

Drugs of abuse increase DA in the Nucleus

Accumbens, which is believed to trigger the

neuroadaptions that result in addiction

Drugs and Natural Rewards ACTIVATE

Dopamine in Reward Regions

Page 3: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Repeated Drug Use Changes the Brain Weakens the Brain Dopamine System

T Y R O S I N E

D A

D O P A

D A

D A

D A

D A

D A

DA

REPEATED USE OF COCAINE OR OTHER DRUGS REDUCES LEVELS OF DOPAMINE D2 RECEPTORS

T Y R O S I N E

D A

D O P A

D A

D A

D A

D A D A D A

D A

D A D A

DA

COCAINE

T Y R O S I N E

D A

D O P A

D A

D A

D A

D A

D A

DA

Control Cocaine Abuser

PLEASURE

Page 4: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Dopamine D2 Receptors are Lower in Addiction

Cocaine

Alcohol

Heroin

Meth

control addicted Volkow et al., Neuro Learn Mem 2002.

1.5

2

2.5

3

3.5

4

4.5

15 20 25 30 35 40 45 50

DA

D2 R

ec

ep

tors

(Ra

tio

In

de

x)

20 25 30 35 40 45 50

1.6

1.8

2

2.2

2.4

2.6

2.8

3

3.2`

Bm

ax

/Kd

Normal Controls Cocaine Abusers

Page 5: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Addiction Involves Multiple Factors

Addiction

DRUG

Brain Mechanisms

DEVELOPMENT/Genes John S

mith Jam

es S

mith

Ann J

ones J

ohn J

ones

Mary

Hill

Walter

Jones

Jam

es H

ill

Susan

Adam

s

Alice P

rice T

hom

as J

ones

Will

iam

Pri

ce

Ric

hard

Hill

Ste

ven A

dam

s

Allis

on F

ield

s

Mary

Walters

Alice B

enson

Rebecca W

ilson

Thom

asS

mith

John S

mith Edw

ard

Sm

ith

AnneC

ook J

aneW

alk

er J

ohn W

alk

er

JaneJones

Susan

Edw

ard

s

Jam

esC

ook

Beth

Bry

son Jonath

anC

ook

Edw

ard

Bry

son

Am

y M

ason

Beth

C

art

er

ENVIRONMENT

Page 6: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Gogtay et al. 2004 Proc. Natl. Acad. Sci. USA 101, 8174-8179.

Dynamic Sequence of GM Maturation

The Brain Undergoes Major Changes From Childhood Through Adulthood

% a

ge

gro

up

wh

o d

evel

op

fir

st-t

ime

can

nab

is u

se d

iso

rder

0.0%

0.2%

0.4%

0.6%

0.8%

1.0%

1.2%

1.4%

1.6%

5 10 15 18 25 30 35 40 45 50 55 60 65 70

Age Age at cannabis use disorder as per DSM IV

NIAAA National Epidemiologic Survey on Alcohol and Related Conditions, 2003

Page 7: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Morgan, D. et al. Nature Neuroscience, 5: 169-174, 2002.

Social Rank & Vulnerability to Drugs

3 months

Dominant

Group Housed

Individual Housed

Subordinate

3 months

Individual Housed

Group Housed

* *

S .003 .01 .03 .1

0

10

20

30

40

50

Cocaine (mg/kg/inj)

Dominant Subordinate

Social Deprivation Interferes with Brain Connectivity

Social Neglect During Early Childhood

Decreases Brain Connectivity

Decreased connectivity between amygdala and OFC wass proportional to time in orphanage.

Govindan et al., Cereb Cortex 2010.

Page 8: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Prevention Programs Should Enhance Protective Factors & Reduce Risk Factors

Reduce these Elevate these

Page 9: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Partial Recovery of Brain Dopamine Transporters in Methamphetamine (METH)

Abuser After Protracted Abstinence

Normal Control METH Abuser (1 month detox)

METH Abuser (14 months detox)

0

3

ml/gm

Source: Volkow, ND et al., Journal of Neuroscience 21, 9414-9418, 2001.

ADDICTION CAN BE TREATED

Page 10: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Opioid Agonist Treatments

Decreased Heroin OD Deaths Baltimore, Maryland, 1995-2009

Heroin overdoses

Buprenorphine patients

Methadone patients

Schwartz RP et al., Am J Public Health 2013.

Medications Assisted Therapies

Methadone Promotes Initiation

Of Antiretroviral Therapy in IDU

Uhlmann S et al., Addiction 2010; 105(5):907-913.

Page 11: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

WORLD DRUG REPORT 2016, UNODC

Around the World…

Page 12: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Challenge: How to Integrate Drug Abuse & Addiction Screening, Prevention & Treatment into the Healthcare System

Page 13: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced
Page 14: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

5.4 5.4 5.6

0.9

2.3 2.4

0

1

2

3

4

5

6

Buprenorphine Referral Brief Intervention

Baseline 30 days

Improving Treatments for Addiction: Implementing Medication-Assisted Treatment

• Emergency department-initiated buprenorphine

– Reduced self-reported, illicit opioid use

– Increased engagement in addiction treatment;

decreased use of inpatient addiction treatment services

Da

ys

Self-Reported Illicit Opioid Use in the Past 7 Days

Page 15: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Children with low self-control had poorer health outcomes and higher problems with substance use disorders than those with high self-control

Childhood Self-Control Predicts Health

(Dunedin Study; 1000 children)

Moffitt et al., PNAS 2011.

Self-control can be improved by: • Computerized training • Non-computerized games • Aerobics • Martial Arts • Yoga • Mindfulness • School Curricula

Interventions that Aid Executive Function In

4 to 12 Years Olds

All successful programs involved repeated practice and progressively increase challenge to executive function

Diamond & Lee. Science 2011.

Page 16: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Medications are Underused

Nearly all U.S. states do not have sufficient treatment capacity to provide medication assisted treatment to all patients with an opioid use disorder

[VALUE]

[VALUE]

MAT No MAT

In 2014, the proportion of opioid

admissions with tx plans that

included receiving medications

was 25%

Treatment Episode Data Set (TEDS): 2004-2014.

Jones C et al., Am J Public Health 2015.

In 48 states and D.C., Opioid Abuse

and Dependence Rates Exceed

Buprenorphine Treatment Capacity

Page 17: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Microstructural Abnormalities in Language and Limbic

Pathways in Orphanage-Reared Children:

A Diffusion Tensor Imaging Study

Association of mean diffusivity of the left arcuate fasciculus and time spent in the adoptive home

Mean diffusivity decreased with increasing time spent in the adoptive environment

Relationship between language function and Fractional Anisotropy (FA) for the left arcuate fasciculus

in children with early deprivation Increases in FA are associated with better language function

Kumar A et. al., J Child Neurology 2014; 29(3): 318-325.

Page 18: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

Duration Of Early Adversity and Structural Brain

Development In Post-institutionalized Adolescents

Hodel AS et al., Neuroimage. 2015 Jan 15;105:112-119.

Prefrontal gray matter volume (age &

sex adjusted) is reduced in PI youth

Duration of early adversity predicts

hippocampal volume reduction

(age and sex adjusted)

Duration of adversity over first year

of life predicts hippocampal volume

(age, sex, and ICV adjusted) in early

adolescence (right hippocampal effect

is equivalent).

Page 19: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

• Neglect in early life was associated with alterations in white matter microstructure throughout the brain,

specifically involving the body of the corpus callosum, cingulum, fornix, anterior and superior corona radiata,

external capsule, retrolenticular internal capsule, and medial lemniscus.

• The foster care group did not significantly differ from the never-institutionalized group in measurements of these

tracts, with the exception of the body of the corpus callosum and superior corona radiata.

• These findings suggest a potential for remediation of specific white matter pathways for children removed from

institutional care and placed in responsive families early in life.

Effect of Early Institutionalization and Foster Care on

Long-Term White Matter Development

Bick J et al., JAMA Pediatr 2015 Mar; 169(3): 211-219.

Multimodal Regression Models Examining Effects of Intervention

Page 20: Neurobiological Advances in Addiction Science...Improving Treatments for Addiction: Implementing Medication-Assisted Treatment •Emergency department-initiated buprenorphine –Reduced

DA

DA

DA

DA DA DA

DA

signal

DA D2 Receptors

Metabolism

Controls Methamphetamine

Abusers

4

0

Controls Alcoholics

Control Cocaine Abuser

Chronic Drug Use Reduces DA D2

Receptors Impairing Frontal

Function

30

40

50

60

70

80

90

2.9

3 3.1

3.2

3.3

3.4

3.5

3.6

D2 Receptors (BPND) 1.5 2 2.5 3 3.5 4

25

30

35

40

45

50

D2R VS

(Bmax/Kd)

Met

abol

ism

CG

(mic

rom

ol/1

00g/

min

)

1.5 2 2.5 3 3.5 422

24

26

28

30

32

34

36

38

D2R VS

(Bmax/Kd)

Met

abol

ism

OFC

(mic

rom

ol/1

00g/

min

)

1.5 2 2.5 3 3.5 430

35

40

45

50

D2R VS

(Bmax/Kd)

Met

abol

ism

Pre

fron

tal

(mic

rom

ol/1

00g/

min

)

30

35

40

45

50

55

60

65

1.8

2 2.2

2.4

2.6

2.8

3 3.2

3.4

D2 Receptors (BPND)

Fro

nta

l M

etab

oli

sm


Recommended